News & Stories
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.
This Press Ganey award recognizes institutions who have maintained consistently high levels of excellence in patient experience over a three-year period.
Five Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer.
A newly awarded $820,000 grant from The National Cancer Institute (NCI) will allow a team of investigators to increase clinical trial awareness and participation for rural patients.